<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04190563</url>
  </required_header>
  <id_info>
    <org_study_id>2019P002720</org_study_id>
    <secondary_id>R01DA045632</secondary_id>
    <nct_id>NCT04190563</nct_id>
  </id_info>
  <brief_title>Pain, Inflammation and Opioid Craving</brief_title>
  <official_title>Affective and Inflammatory Reactivity to Pain in Opioid Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mclean Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mclean Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to investigate the association between response to pain and opioid
      craving in people with opioid use disorder. In this study, adults with opioid use disorder
      will be randomized to one of two brief education sessions followed by an assessment of
      response to pain. Investigators will test the association between response to pain and opioid
      craving.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>The investigator and data analyst will be blind to study condition.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Craving</measure>
    <time_frame>30 minutes</time_frame>
    <description>Investigators will assess opioid craving using the Opioid Craving Scale, a participant-reported measure of opioid craving. Investigators will measure changes in Opioid Craving Scale total scores from baseline (prior to the one-time intervention) to immediately after the intervention. This is a continuous measure that will be measured twice within this single-session experimental session. The total scale score is calculated as an average of the 3 items, with a range from 0-10, with higher scores reflecting more craving.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Opioid-use Disorder</condition>
  <arm_group>
    <arm_group_label>Pain De-Catastrophizing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brief behavioral education on how to modify the interpretation of pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pain Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Brief behavioral education on pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pain De-Catastrophizing</intervention_name>
    <description>Experimenter-administered education and skill practice.</description>
    <arm_group_label>Pain De-Catastrophizing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pain Education</intervention_name>
    <description>Experimenter-administered education.</description>
    <arm_group_label>Pain Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or older;

          -  diagnosis of opioid use disorder

          -  chronic pain

          -  ability to read and provide informed consent

        Exclusion Criteria:

          -  major psychiatric or medical condition that would interfere with participation

          -  current opioid withdrawal

          -  currently receiving opioid analgesic medication for pain

          -  recent history of myocardial infarction or other serious cardiovascular condition

          -  current peripheral neuropathy, active vasculitis or severe peripheral vascular disease

          -  systematic inflammatory or autoimmune disorder

          -  admitted to current treatment episode on an involuntary status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca K McHugh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mclean Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca K McHugh, PhD</last_name>
    <phone>617-855-2000</phone>
    <email>kmchugh@mclean.harvard.edu</email>
  </overall_contact>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>June 12, 2020</last_update_submitted>
  <last_update_submitted_qc>June 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mclean Hospital</investigator_affiliation>
    <investigator_full_name>McHugh, R. Kathryn</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

